Aggressive versus moderate lipid-lowering therapy in postmenopausal women with hypercholesterolemia: Rationale and design of the Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES) trial

American Heart Journal

Volumn 141, Issue 5, 2001, Pages 722-726

  Raggi, Paolo ^a   Callister, Tracy Q ^b   Davidson, Michael ^c   Welty, Francine K ^d   Bachmann, Gloria A ^e   Laskey, Rachel ^f   Pittman, Donald ^f   Kafonek, Stephanie ^f   Scott, Robert ^f  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Electron Beam Tomography Research Foundation   (United States)

^c RADIANT RESEARCH   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^f PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIAGNOSTIC IMAGING; DISEASE SEVERITY; DRUG INDUCED DISEASE; DRUG SAFETY; ELECTRON BEAM TOMOGRAPHY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT OUTCOME;

EID: 0035029222     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2001.114372     Document Type: Article

References (29)

1. Metabolic risk factors for coronary heart disease in women: Perspective from the Framingham Study
2. Coronary artery disease: Improved reproducibility of calcium scoring with an electron-beam CT volumetric method
3. Electron beam computed tomographic coronary calcium scanning: A review and guidelines for use in asymptomatic persons
4. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography
5. Postmenopausal hormone use for cardioprotection: What we know and what we must learn
6. Effects of estrogens on lipoprotein metabolism and cardiovascular disease in women
7. The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease
8. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women: Heart and Estrogen/progestin Replacement Study (HERS) Research Group
9. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease
10. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels: Cholesterol and Recurrent Events Trial investigators
11. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
12. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS: Air Force/Texas Coronary Atherosclerosis Prevention Study
13. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts
14. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease: Atorvastatin versus Revascularization Treatment Investigators
15. Angiographic progression of coronary artery disease and the development of myocardial infarction
16. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?
17. Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography
18. Coronary plaque disruption
19. Lipid lowering and plaque regression: New insights into prevention of plaque disruption and clinical events in coronary disease
20. Our preoccupation with coronary luminology: The dissociation between clinical and angiographic findings in ischemic heart disease
21. Compensatory enlargement of human atherosclerotic coronary arteries
22. In vivo validation of compensatory enlargement of atherosclerotic coronary arteries
23. Focal compensatory enlargement of human arteries in response to progressive atherosclerosis: In vivo documentation using intravascular ultrasound
24. Coronary artery calcification: Assessment with electron beam CT and histomorphometric correlation
25. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: A histologic study of 723 coronary artery segments using nondecalcifying methodology
26. Predictive value of electron beam computed tomography of the coronary arteries: 19-Month follow-up of 1173 asymptomatic subjects
27. Measuring the effect of risk factors on coronary atherosclerosis: Coronary calcium score versus angiographic disease severity
28. Cardiac events in patients with progression of coronary calcification on electron beam computed tomography